Publications

Filters: Keyword is Morpholines  [Clear All Filters]
2011
Dolan BP, Li L, Veltri CA, Ireland CM, Bennink JR, Yewdell JW.  2011.  Distinct pathways generate peptides from defective ribosomal products for CD8+ T cell immunosurveillance.. Journal of immunology (Baltimore, Md. : 1950). 186(4):2065-72. Abstract
Crisp A, Yin H, Goyenvalle A, Betts C, Moulton HM, Seow Y, Babbs A, Merritt T, Saleh AF, Gait MJ et al..  2011.  Diaphragm rescue alone prevents heart dysfunction in dystrophic mice.. Human molecular genetics. 20(3):413-21. Abstract
2010
Moulton HM, Moulton JD.  2010.  Morpholinos and their peptide conjugates: therapeutic promise and challenge for Duchenne muscular dystrophy.. Biochimica et biophysica acta. 1798(12):2296-303. Abstract
Eide K, Moerdyk-Schauwecker M, Stein DA, Bildfell RJ, Koelle DM, Jin L.  2010.  Reduction of herpes simplex virus type-2 replication in cell cultures and in rodent models with peptide-conjugated morpholino oligomers.. Antiviral therapy. 15(8):1141-9. Abstract
2009
Moerdyk-Schauwecker M, Stein DA, Eide K, Blouch RE, Bildfell RJ, Iversen P, Jin L.  2009.  Inhibition of HSV-1 ocular infection with morpholino oligomers targeting ICP0 and ICP27.. Antiviral research. 84(2):131-41. Abstract
2008
Smith AW, Iversen PL, O'Hanley PD, Skilling DE, Christensen JR, Weaver SS, Longley K, Stone MA, Poet SE, Matson DO.  2008.  Virus-specific antiviral treatment for controlling severe and fatal outbreaks of feline calicivirus infection.. American journal of veterinary research. 69(1):23-32. Abstract